Multicomponent reactions;
Ugi reaction;
Ugi 5-center-4-component reaction;
2-Oxopiperazines;
Molecular diversity;
ACIDS;
KETOPIPERAZINES;
DERIVATIVES;
INHIBITORS;
CATALYSIS;
5-CENTER;
D O I:
10.1007/s11030-023-10760-1
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
A synthetic route leading to densely functionalized 2-oxopiperazines is presented. The strategy employs a 5-center-4-component variant of Ugi multicomponent reaction followed by a deprotection/cyclization sequence. N-Boc-alpha-amino aldehydes were used for the first time as carbonyl components in a key Ugi 5-center-4-component reaction (U-5C-4CR). It is shown that the presented synthetic route can lead to rigid, heterocyclic scaffolds, as demonstrated by the synthesis of tetrahydro-2H-pyrazino[1,2-a]pyrazine-3,6,9(4H)-trione beta-turn mimetic and derivatives of 1,6-dioxooctahydropyrrolo[1,2-a]pyrazine and 3,8-dioxohexahydro-3H-oxazolo[3,4-a]pyrazine.
机构:
Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China
Peking Union Med Coll, Beijing 100050, Peoples R China
Shenyang Pharmaceut Univ, Dept Pharm Engn, Shenyang 110016, Peoples R ChinaChinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China
Zhao, Hai-Long
Zhou, Jie
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China
Peking Union Med Coll, Beijing 100050, Peoples R ChinaChinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China
Zhou, Jie
Song, Hong-Rui
论文数: 0引用数: 0
h-index: 0
机构:
Shenyang Pharmaceut Univ, Dept Pharm Engn, Shenyang 110016, Peoples R ChinaChinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China
Song, Hong-Rui
Xu, Bai-Ling
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China
Peking Union Med Coll, Beijing 100050, Peoples R ChinaChinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China